| scholarly article | Q13442814 |
| P2093 | author name string | Y Zhang | |
| M Kimura | |||
| H Nagase | |||
| T Yasuda | |||
| A Matsuzawa | |||
| C R Wang | |||
| T Yoshimoto | |||
| M Takamoto | |||
| A Tsubura | |||
| P2860 | cites work | Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 |
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms | Q33928012 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Host modifier genes affect mouse autoimmunity induced by the lpr gene | Q35764934 | ||
| Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells | Q35765175 | ||
| Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci | Q36232118 | ||
| A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse | Q36350481 | ||
| Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice | Q36362973 | ||
| Molecular genetics of murine lupus models | Q38692994 | ||
| Fas and Fas ligand: lpr and gld mutations | Q40398275 | ||
| Autoimmunity in mice bearing lprcg: a novel mutant gene | Q40635194 | ||
| Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice | Q41117425 | ||
| Reduced development of CD4-8-B220+ T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules | Q41664431 | ||
| The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice | Q42019842 | ||
| Constitutive expression of high levels of soluble mouse CD4 in transgenic mice does not interfere with their immune function | Q44271114 | ||
| Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice | Q45011727 | ||
| Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. | Q45943164 | ||
| Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. | Q52206363 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice | Q60998067 | ||
| Immunological characterization of C3H mice congenic for Fas(lprcg), C3h/HeJ-Fas(lprcg)/Fas(lprcg) | Q64388610 | ||
| Long-term anti-CD4 treatment of MRL/lpr mice ameliorates immunopathology and lymphoproliferation but fails to suppress rheumatoid factor production | Q68033777 | ||
| Nephritogenicity of the lprcg gene on the MRL background | Q68046895 | ||
| Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin | Q68575559 | ||
| Treatment of murine lupus with monoclonal anti-T cell antibody | Q69863949 | ||
| Murine models of systemic lupus erythematosus | Q69894910 | ||
| Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice | Q71243470 | ||
| In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells | Q71651086 | ||
| Reduction of mortality and lymphadenopathy in MRL-lpr/lpr mice treated with nonmitogenic anti-CD3 monoclonal antibody | Q72340231 | ||
| Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice | Q72658815 | ||
| Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice | Q72670029 | ||
| Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease | Q72692778 | ||
| Novel mutant mice secreting soluble CD4 without expression of membrane-bound CD4 | Q74375570 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 124-132 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice | |
| P478 | volume | 122 |
Search more.